BIOTON S.A.

zł 3.46As of Sun 8 Nov 2026, 12:00 UTC
WSE:BIOHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR (8.91%)
Div yield —
ROE (1.43%)
Biotechnology
Beta (5Y) 0.19
PE TTM —
TSR TTM (19.16%)
Mkt cap zł 297.1M
ROIC (0.54%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 4.21
21.59%
(68.84%)
Hold 2|8|1|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.05
0.05
0.06
0.06
7.68%
5.47%
13.00%
20.21%
Revenuezł M
15.41
15.87
15.79
16.31
3.20%
0.80%
3.25%
9.87%
Peers (US$75.03M)
Cap (US$)
PE
96.40M
—
Capital
TTM
5Y
10Y
Leveragex
5.535
0.090
0.078
EBIT/Intx
2.058
0.305
0.270
Own earn%
122.69
69.21
66.49
Sh yield%
19.90
36.86
40.46
Owners
Insiders/Inst%
8.58
79.44
Short interest%
1.13
SBC / revenue%
2.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
28–35
$1 testx
0.0
Incr. ROIC%
13